LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 juin 2024 16h10 HE | Vislink Technologies, Inc.
Mt. Olive, NJ, June 18, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective June 17, 2024, Donald Gilliam was granted a...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 févr. 2024 17h10 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
13 févr. 2024 16h05 HE | Vislink Technologies, Inc.
Mt. Olive, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective February 12, 2024, Adrian Lambert was granted a...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02 janv. 2024 17h23 HE | Vislink Technologies, Inc.
Mt. Olive, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective January 1, 2024, Bill Sweeney was granted a...
LogoVislink2022_2.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07 juil. 2023 16h30 HE | Vislink Technologies, Inc.
Mt. Olive, NJ, July 07, 2023 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that on July 5, 2023, Steven Teese was granted a time-based...
Atyr_Logo.png
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 août 2022 16h05 HE | aTyr Pharma, Inc.
SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
Atyr_Logo.png
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 mai 2022 16h00 HE | aTyr Pharma, Inc.
SAN DIEGO, May 13, 2022 (GLOBE NEWSWIRE) --  aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
Logo new.jpg
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 janv. 2020 17h00 HE | Vislink Technologies, Inc.
HACKETTSTOWN, NJ, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. announced today that on January 22, 2020 Carleton Miller was granted a time-based and performance-based non-qualified...